The Irish cohort has been divided into two study groups according to the availability of genotyping
IFNL3 T+ | IFNL3 CC | HLA Class I | HLA Class II | |
---|---|---|---|---|
Group 1 n=319 | 163 | 156 | 319 | — |
SR | 29 | 94 | 124 | — |
Chronic | 134 | 62 | 196 | 136 |
Group 2 n=213 | 110 | 103 | 213 | 213 |
SR | 21 | 56 | 77 | 77 |
Chronic | 89 | 47 | 136 | 136 |
SR, spontaneous resolver.